CITALOPRAM HYDROBRO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F3747 to DMS Pharmaceutical Group Inc for the procurement of Citalopram Hydrobromide under the broader delivery order SPE2DX25D9900. This delivery order is part of a larger commercial items contract issued by the DLA Troop Support Medical Supply Chain FSB, which has a total award value of 19,999,999.00 dollars and was effective as of April 2, 2025. Despite the initial award, modification P00001 dated March 25, 2026, served as a contract cancellation. The government exercised its right to terminate for convenience under FAR 52.212-4, resulting in the cancellation of CLIN 0001 at no cost or liability to either party. This modification decreased the order amount from 10.32 dollars to 0.00 dollars, effectively cancelling the subject order.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
